The Effect of Sacubitril-Valsartan on Ventricular Arrhythmia Burden in Patients With Heart Failure With Reduced Ejection Fraction

Introduction Heart failure with reduced ejection fraction (HFrEF) patients are prone to developing ventricular arrhythmias. In the PARADIGM-HF trial, sacubitril-valsartan (SV) showed a reduction in the composite endpoint of death and HF hospitalization in HFrEF patients; subgroup analysis of this tr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Curēus (Palo Alto, CA) CA), 2023-02, Vol.15 (2), p.e34508
Hauptverfasser:	Medeiros, Paulo, Coelho, Cláudia, Costa-Oliveira, Cátia, Rocha, Sérgia
Format:	Artikel
Sprache:	eng
Schlagworte:	Blood pressure Cardiac arrhythmia Cardiology Cardiovascular disease Coronary vessels Diabetes Diuretics Ejection fraction Enzymes Heart failure Hypertension Internal Medicine Kidney diseases Mann-Whitney U test Metabolic disorders Normal distribution Patients Statistical analysis Vein & artery diseases
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!